top of page
 THE PACE

New therapies / indications available since the last 12 months 

XACDURO®

BY:

Dr. Feng Xue

Apr 28, 2026

  • 微信图片_20260414172211_190_280
  • 微信图片_20260414172239_191_280

XACDURO®

(durlobactam, as sodium; sulbactam, as sodium) ZAI LAB HK Reg. No. HK-68971 (29 Jan, 2026)   

 

Composition3:XACDUROA® is a co-packaged kit containing the following two components as sterile powders for reconstitution:

• 1 clear single-dose vial of sulbactam for injection 1 g and

• 2 amber single-dose vials of durlobactam for injection 0.5 g

 

Indication3:XACDURO® is indicated in patients 18 years of age and older for the treatment of hospital acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP), caused by susceptible isolates of Acinetobacter baumannii-calcoaceticus complex

 

 

References
3. FDA. Highlights of Prescribing Information. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216974s000lbl.pdf. [Accessed 12 March 2026].

POPULAR STORY

Uncovering the Tricks of the Silent Thief of Sight

Dr. Roy Lau

Dec 19, 2024

What’s New in Coronary Artery Disease?

Dr. Roy Lau

Aug 20, 2024

Challenges and Strategies for Managing CHB Patients with Co-morbidities

Dr. Roy Lau

Jun 21, 2024

Decoding the Paradox on Impact of Obesity on Cognitive Functioning

Dr. Roy Lau

Jun 20, 2024

Gain Without Pain – Revisiting the Pain Management in Rheumatoid Arthritis

Dr. Roy Lau

Oct 22, 2024

Uncovering the Art of Perfect Matching – A Review on Precision Oncology

Dr. Roy Lau

Feb 17, 2025

bottom of page